Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local Level Grant

About Pfizer Grants
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
About Pfizer QI Grants
Quality improvement (QI) projects are systematic, data-guided, sustainable activities designed to bring about immediate, positive changes in the delivery of healthcare in particular setting. Quality improvement seeks to standardize structure and processes to reduce variation, achieve predictable results, and improve outcomes for patients, healthcare systems, and organizations. Structure includes things like technology, culture, leadership, and physical capital. Process includes knowledge capital (e.g., standard operating procedures) or human capital (e.g., education and training).
Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local Level
Overview
This competitive program seeks to optimize and continuously improve the quality of care for patients with atopic dermatitis (AD) in provincial, city or county level. Quality improvement initiatives to be supported should be focused on addressing the practical challenges of implementing key quality control (QC) standards, Treat to Target (T2T) guidelines or doctor-patient Shared Decision-Making (SDM) for AD, optimizing long-term management for adolescent and adult patients with AD.
Project Types and Area of Interest
Applicants are encouraged to identify gaps in current practice and implement sustainable solutions to improve AD quality of care across regional healthcare systems. Areas of interest include:
Strengthening AD clinical practice at provincial, city, or county levels through effective execution of QC standards or T2T guidelines.Addressing practical challenges in implementing QC processes to ensure long-term, consistent quality improvement.Developing annual reports to track year-over-year progress and sustain ongoing improvements.Advancing SDM in AD care through the development and refinement of decision-support tools, workflow integration assessments, and mitigation of implementation barriers.
Target Audience
Dermatologists and other relevant HCPs that diagnose and treat patients with Atopic Dermatitis (AD).